Biotechnology company Medistem Inc. (MEDS.PK: News ) has hit a milestone , following regulatory approval to begin a clinical trial in the U.S. with its lead product candidate endometrial regenerative cell stem cell product. The endometrial regenerative cell, or ERC for short, is a "universal donor" stem cell derived from the menstrual blood that possesses the … [Read more...]
Non-controversial Stem Cells
March 29, 2008 By
Medistem's Endometrial Regenerative Cells appear on NBC 739 1st News at 4:00. … [Read more...]
MSNBC – Menstrual blood tapped as source of stem cells
November 30, 2007 By
While the excitement continues to swirl around the recent breakthrough of converting skin cells to stem cells , other researchers are quietly pursuing a new type of stem cell discovered in menstrual blood. These menstrual stem cells could offer several advantages. They come from a source that's easy to obtain from women, they could be used to treat patients … [Read more...]